Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Effect on Performing Humphrey Visual Fields
NCT02162381Completed
- Sponsor
- Rabin Medical Center
- Start
- Jun 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of methylphenidate hydrochloride extended-release chewable tablet in visual field defect (VFD) (2 arms), sponsored by Rabin Medical Center. Primary endpoint: Improvement rate of a repeat visual field result. Started Jun 2014; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
visual field defect (VFD)
Beyond the preview
Go deeper on NCT02162381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162381.